Research trends and collaboration patterns in robotic retroperitoneal lymph node dissection for testicular cancer

Demirhan Örsan Demir1, Çağrı Öktem2, Yusuf Gökkurt3

  • 1Department of Urology, Ankara Bilkent City Hospital, Ankara, Turkey. demirhanorsan.demir@sbu.edu.tr.

Insights

Robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer shows increasing publications. Research focuses on minimally invasive techniques and outcomes, with key contributions from specialized centers.

Area of Science:

  • Urology
  • Surgical Oncology
  • Minimally Invasive Surgery

Background:

  • Robotic retroperitoneal lymph node dissection (RPLND) is a growing minimally invasive treatment for testicular cancer.
  • Publication trends and the scientific landscape of robotic RPLND literature require evaluation.

Purpose of the Study:

  • To perform a bibliometric analysis of global literature on robotic RPLND in testicular cancer.
  • To identify publication trends, collaboration patterns, and research themes.

Main Methods:

  • Bibliometric analysis of 93 publications (2006-2025) using Biblioshiny and VOSviewer.
  • Examination of publication output, citations, leading journals/institutions, collaborations, and keyword co-occurrence.

Main Results:

  • Annual publications increased, peaking in 2021 and 2025.
  • Journal of Robotic Surgery and World Journal of Urology were leading journals; Johns Hopkins University led institutions.
  • The United States dominated publications, citations, and collaborations. Key themes included robotic surgery, minimally invasive approaches, post-chemotherapy disease, and nonseminomatous germ cell tumors.

Conclusions:

  • Literature on robotic RPLND for testicular cancer is expanding.
  • Research is concentrated in specialized centers, focusing on surgical techniques and outcomes.
  • This analysis maps the field's evolution, collaborations, and core research areas.

Related Concept Videos